Who are we?


Bellacanna Enterprises is an investment collective, started by two entrepreneurs from the historic Howard University, that strategically fuses social, intellectual and financial capital into high-growth cannabis companies worldwide. Our strategy provides technical expertise, cultural competency and guidance for dynamic organizations seeking to impact the global market.

Focused on diversity and inclusion in the following areas:

Cultivation – Processing – Sustainability – Data – Media – Tech

USA AND AFRICA FOCUS


The legalization and new government support for hemp production in the United States and Africa is creating a fast-growing industry. We believe this presents an extraordinary opportunity for social and economic impact for small businesses and underserved communities around the world if integrated into the global hemp value chain.

We believe Africa will  be a vital source of hemp production. Africa has more than 50% of the world’s remaining arable land, is expected to have the world’s largest workforce by 2050 and has preferential access to the US market through AGOA.

With our footprints in the US, Africa and Europe, we can link hemp producers to the global market. With our plant-science, processing and product development expertise, we are setting up a world-class ecosystem of cannabis producers.

WHY NOW


Bellacanna Enterprises, our portfolio companies and our network partners are here to breakdown the challenges and accelerate opportunities of an emerging global dominator like industrial hemp that has skyrocketed growth and evolution and continues to outpace effective regulations.

THE GLOBAL INDUSTRIAL HEMP IS PROJECTED TO GROW FROM USD 4.6 BILLION IN 2019 TO USD 26.6 BILLION BY 2025 WITH A CAGR OF 34% ACCORDING TO BUSINESS WIRE.

Through sustainable solutions, diverse leadership and investment in the next generation of innovators and creators – industrial hemp has the potential to create unforeseen first generational wealth opportunities and dynamic portfolio returns.

SEASONED ENTREPRENEURS AND PROFESSIONALS

Our principals are seasoned entrepreneurs and professionals that can relate to the problems business owners can encounter operating their organizations. Through previous endeavors our team has worked together for many years, we pride ourselves on preserving company culture, manifesting new ideas, talent and incorporating your vision.

Chris Isaacs

Chief Executive Officer

Founded a successful healthcare govcon business in Washington DC. Has led government contract acquisitions of nearly  $90M. Mr Isaacs has invested in several minority founder led startups including Taste Makers Africa.

Stephanie Jolly

Chief Scientific Officer - Group

Stephanie Jolly is one of only seven original licensed cannabinoid scientists in the United States, and stands alone as the only one without a collegiate affiliation.

Sydney Hall

Chief Executive Officer - Africa

Sydney is a veteran of the medical cannabis cultivation and dispensing world,
having cultivated some of the best proprietary strains California medical
cannabis market

Mandla Lionel Isaacs

Chief Strategy Officer - Group

Strategy, operations, communication, government relations and regulatory

Patricia Edwards

Chief Investment Officer - Group

Business & ecosystem Development, investor relations, strategic communications, innovation

Stefan Poppe

Chief Technology Officer - Group

Technology, Programming, IoT, Virutal Reality, BlockChain, AI/Machine learning.

JAKE JASON TIMM

Business Developer

Christ Kituantala

Creative Director Media

BELLA CANNA ENTERPRISE ADVISORY BOARD

Dr. Dominique Carter

Advisory Board

Dominique is a 2017-2018 National Science Foundation Science and Technology Policy Fellow in the Office of International Science and Engineering in the Office of the Director.

Dr. Walter Calvin Damper

Advisory Board

is an interventional spine, pain and sport specialist. Dr. Damper received his bachelor’s degree in biology from Cumberland College in Williamsburg, Kentucky.

Yusuf Henriques

Advisory Board

Yusuf is a veteran scientist, Co-Founder & CEO of CodeClear Ventures, Inc. and Founder of TruGenomix Health, Inc.